Tom Daschle

See the following -

A 'Very Graphic History' Of Germ Warfare

Press Release | Blue Ribbon Study Panel on Biodefense | April 25, 2019

Max Brooks, best-selling author of "World War Z" and non-resident fellow at the Modern War Institute at West Point, has partnered with the Blue Ribbon Study Panel on Biodefense to produce GERM WARFARE: A Very Graphic History. This highly stylized and engaging graphic novel, set for release this Saturday, depicts previous biological warfare events, the possibilities for the future, and the continued need for public health security. This is part of an effort by the bipartisan Panel to educate the public about biological risks and why a strong biodefense enterprise is critical to the health and security of the Nation.

Read More »

Bipartisan Policy Center's Health Innovation Initiative: Health IT Industry Officials Lying To Regulators With Impunity?

InformaticsMD | Health Care Renewal | February 14, 2013

A statement that health IT has a "lower risk profile" compared to other regulated healthcare sectors such as devices or drugs, in order to seek continued and extraordinary regulatory accommodations, is remarkable.  It is either reckless regarding something that the statement's makers should know, or should have made it their business to know - or a deliberate prevarication with forethought.

Read More »

Blue Ribbon Study Panel On Biodefense Receives $2.5 Million Grant To Reduce Risk of Catastrophic Bioweapon Disease Outbreaks

Press Release | Blue Ribbon Study Panel on Biodefense | February 15, 2018

The Blue Ribbon Study Panel on Biodefense announced today a $2.5 million grant from the Open Philanthropy Project. The grant allows the Panel to continue its leadership role in assessing our nation’s biodefense, issuing recommendations and advocating for their implementation, and identifying viable avenues for needed change to policy. The grant comes amidst heightened global tensions as North Korea and other regimes seek to develop biological weapons. It also arrives on the 100th anniversary of a catastrophic influenza pandemic that took the lives of millions around the world, a stark reminder of the dangers of biological events.

Read More »

Clade X pandemic exercise highlights policies needed to prevent or reduce the worst possible outcomes in future pandemics

Press Release | Johns Hopkins Center for Health Security | May 15, 2018

The outbreak of a moderately contagious and moderately lethal novel pathogen precipitated a catastrophic end to the scenario in Clade X, the day-long pandemic tabletop exercise hosted by the Johns Hopkins Center for Health Security on May 15 in Washington, DC. Clade X simulated a series of National Security Council–convened meetings of 10 US government leaders, played by individuals prominent in the fields of national security or epidemic response. Their dialogue as the scenario unfolded addressed significant uncertainties in current prevention and response capabilities, hamstrung by policy challenges at the federal level.

This mock pandemic killed 150 million people. Next time it might not be a drill

Lena H. Sun | Washington Post | May 30, 2018

A novel virus, moderately contagious and moderately lethal, has surfaced and is spreading rapidly around the globe. Outbreaks first appear in Frankfurt, Germany, and Caracas, Venezuela. The virus is transmitted person-to-person, primarily by coughing. There are no effective antivirals or vaccines...So began a recent day-long exercise hosted by the Johns Hopkins Center for Health Security. The simulation mixed details of past disasters with fictional elements to force government officials and experts to make the kinds of key decisions they could face in a real pandemic. It was a tense day. The exercise was inspired in part by the troubled response to the Ebola epidemic of 2014, and everyone involved was acutely aware of the very real and ongoing Ebola outbreak spreading in Congo.

Read More »

Top White House Biodefense Official to Address Bipartisan Panel

Press Release | Blue Ribbon Study Panel on Biodefense | November 12, 2018

The Trump Administration recently released a National Biodefense Strategy to better defend the United States against myriad biological threats. The development and implementation of a comprehensive national biodefense strategy were among the top recommendations made by the bipartisan Blue Ribbon Study Panel on Biodefense in 2015. This Wednesday, November 14, the Panel will convene at the Hudson Institute in Washington, D.C. to gain a better understanding of how far the Executive Branch has come in implementing its National Blueprint for Biodefense.

Read More »

Verizon, WellPoint, CVS, Walgreens Ally With Former Senators To Push Telehealth Policy Reform

Deanna Pogorelc | MedCity News | February 11, 2014

A cohort of big players in connected health is joining three former senators in pursuit of policy that supports broad use of telehealth and remote patient monitoring. Read More »

Ways EHRs Can Lead To Unintended Safety Problems

Kevin B. O’Reilly | American Medical News | February 25, 2013

Wrong records and failures in data transfer impede physicians and harm patients, according to an analysis of health technology incidents. Read More »